In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Charles Sanchez’s HIV journey inspired his hit web series, “Merce.”
Understanding the connections between sex work and HIV
The Impact of Hurricane Maria on HIV
Aprende más sobre la prevención y el tratamiento del VIH para mantenerse saludable.
Our current cover subject, Charles Sanchez, talks combining his acting skills and HIV activism to create a musical comedy web series.
OutServe-SLDN assists military living with HIV who are facing more challenges to serving their country.
Provincetown’s AIDS memorial “stops one ocean moment in time.”
Why ACT UP protested two AIDS-themed art exhibits at the Whitney
Global experts agree: Science does not back HIV crime laws.
Pose and the Latex Ball serve HIV realness.
Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), analyzes data from a 2018 UNAIDS report.
AIDS United reminds people living with HIV that the 2018 election isn’t just about seats in Congress.
A social media recap of AIDS 2018.
Here are some important dates in AIDS history.
The newly released PARTNER2 study documented 77,000 condomless anal sex acts between mixed-HIV-status men; Opposites Attract had 12,000.
The single-tablet antiretroviral regimen includes Janssen’s darunavir plus Gilead’s cobicistat, emtricitabine and tenofovir alafenamide.
Among a group of largely HIV-positive gay and bi men, Zepatier (grazoprevir/elbasvir) boasted a 99 percent cure rate.
This association held true even when researchers controlled for changing rates of viral suppression of HIV in 2012 to 2016 records.
Ninety-six–week data from the Phase I/IIa trial showed the mosaic vaccine was safe and offered a broad and durable immune response.
Compared with a regimen based on Prezista, doravirine was better for blood lipids, including cholesterol and triglycerides.
Scientists have discovered a swifter and more precise way to edit the genome of immune cells, opening doors for cancer and HIV therapies.
After a decade of phenomenal growth, donor funding for low- and middle-income nations fell 7 percent between 2012 and 2017.
Jesús Guillén fights for HIV long-term survivors.
Read the digital edition!